PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug Discovery
How PROTACs and molecular glues are redefining drug discovery through targeted protein degradation strategies.
Mrudula Kulkarni | Feb 13, 2026
20260213135839.webp)
Neuroinflammation As A Target Class: The New Frontier In CNS Drug Development
Why neuroinflammation is emerging as a major target class reshaping CNS drug development and neurology research.
Vaibhavi M. | Feb 13, 2026
Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing
How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.
Mrudula Kulkarni | Feb 12, 2026
20260212173840.webp)
Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines
How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
Vaibhavi M. | Feb 12, 2026
20260127105020.webp)
Engineered Microbes for APIs
How engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.
Mrudula Kulkarni | Jan 27, 2026
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news